Anavex Life Sciences Corp (AVXL)

[sokol]

Yes, all attention will focus on Biogen at the AAIC. It will be business as usual. There will be some at the AAIC that benefit from the infusion market, which is a growth industry, including physician owned centers, physicians with infusion rooms, those involved in homecare,etc. Plus, let's face it, stock analysts and Wall Street in general have much to gain by covering large pharmaceutical companies than a tiny unknown company such as Anavex. The same goes for those that write articles for scientific journals. Who the heck in these professions would be interested in a pill that may conceivably prevent progression of Alzheimer's, Parkinson's, and other debilitating CNS diseases. A pill that may allow these patients to resume their activities and regain their independence. Would nursing home facilities and home care companies advocate the development and approval of such a pill that may reduce the need for their facilities and services?

What is the costs of Alzheimer's care alone?

""Alzheimer’s is the most expensive disease in America, costing more than cancer and heart disease. .....In 2018, the direct costs to American society of caring for those with Alzheimer’s and other dementias will total an estimated $277 billion."

http://act.alz.org/site/DocServer/2012_Costs_Fact_Sheet_version_2.pdf?docID=7161

And these crazy Anavex people advocate development and approval of a pill to eliminate the enormous market for "treating" and "caring for" this old and otherwise usless dependent population. What a travesty! Stop Anavex Now!